Clinical Trials Logo

Filter by:
NCT ID: NCT06335966 Recruiting - Esophageal Cancer Clinical Trials

BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy

BEST-RPP
Start date: January 25, 2024
Phase:
Study type: Observational

Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.

NCT ID: NCT06335953 Recruiting - Clinical trials for Mild Cognitive Impairment

ALIGN: Aligning Medications With What Matters Most (Demonstration)

Start date: May 7, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effectiveness of a pharmacist-led, primary care-based de-prescribing intervention for people living with dementia (PLWD) and the person's care partners. The intervention consists of the following strategies: 1) a de-prescribing educational brochure designed to activate the patient and care partner; 2) a single telehealth visit in which an embedded clinical pharmacist discusses the benefits and harms of the patient's medications with the patient and care partner in the context of the person's goals and preferences; and 3) pharmacist-PCP communication in which the pharmacist provides tailored de-prescribing recommendations designed to be useful and actionable for the PCP. The investigators will compare the intervention group with the waitlist control group to see if there is a difference in the primary outcome, the proportion of patients who deprescribe at least one medication by 3 months.

NCT ID: NCT06335875 Recruiting - Bipolar Disorder Clinical Trials

Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones

BIPO
Start date: May 2024
Phase: N/A
Study type: Interventional

Small exploratory open-label pilot study to assess supplementation of a ketone ester (Juvenescence) combined with a 'ketogenic-mimicking diet' as a potential therapy for persons with bipolar disorder.

NCT ID: NCT06335823 Recruiting - IUD Insertion Pain Clinical Trials

Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology

Start date: June 5, 2024
Phase: N/A
Study type: Interventional

Pain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain. Transcutaneous electric nerve stimulators (TENS) are a non-invasive procedure that may help reduce the pain with IUD insertions. The investigators hope that the information gleaned from this study will result in pain control options for future patients who desire an IUD placement.

NCT ID: NCT06335810 Recruiting - Obesity Clinical Trials

Reducing Obesity Using Social Ties Program

ROBUST
Start date: April 5, 2024
Phase: N/A
Study type: Interventional

This trial aims to test the feasibility and acceptability of addressing interpersonal barriers to weight-related behavior change. Specifically, the study will test if, by including up to two friends, family members, or co-workers in a lifestyle intervention for weight loss, the person enrolled in the study loses more weight than someone whose friends, family members, or co-workers were not invited to participate.

NCT ID: NCT06335758 Recruiting - Clinical trials for Any Solid Oral Medication

Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

RegStud
Start date: January 15, 2024
Phase:
Study type: Observational

The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication. The study will evaluate and monitor use of ReX in respect of: - treatment duration - adverse events - patient adherence and compliance - engagement with ReX via patient-reported outcomes Patients participating in the study will receive their normal medication as standard of care via ReX. Progress will be monitored via patients' responses to questions presented on the ReX touch screen.

NCT ID: NCT06335719 Recruiting - Facial Paralysis Clinical Trials

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

A research study to find out if brief intraoperative electrical stimulation therapy improves nerve regeneration and smile outcomes following two-stage cross face nerve graft facial reanimation surgery.

NCT ID: NCT06335667 Recruiting - Clinical trials for Muscle-Invasive Bladder Cancer

mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

Start date: March 27, 2024
Phase: N/A
Study type: Interventional

This is a pilot, single arm, prospective study that aims to validate the accuracy of the VI-RADS score obtained via multi-parametric magnetic resonance imaging (mpMRI) compared to pathologic cancer stage obtained via diagnostic transurethral bladder tumor resection (TURBT) as well as compare the clinical and quality of life outcomes between these diagnostic modalities in patients with suspected muscle-invasive bladder cancer (MIBC).

NCT ID: NCT06335381 Recruiting - Clinical trials for Severe Maternal Morbidity

MOMs Chat and Care Study

MOMs-CC
Start date: May 28, 2024
Phase: N/A
Study type: Interventional

The purpose of this pragmatic, randomized clinical trial designed to test the effectiveness of an integrated care model approach at two different levels of intensity designed to facilitate timely, appropriate care for high-risk Black birthing people and reduce risk for severe maternal morbidity (SMM). Eligible Black birthing people (n = 674) will be recruited and randomized to one of two study arms: MOMs High-Touch (MOMs-HT) vs. MOMs Low-Touch (MOMs-LT). The two study arms will be compared on incidence of SMM at labor and delivery (Aim 1), incidence rate of SMM-related hospitalizations at 1-month and 1-year postpartum (Aim 1a), time to preeclampsia diagnosis and initiation of treatment (Aim 2), change in perceived social support domains (Aim 3), and physical activity trajectories (exploratory Aim 4). Mixed methods will also be used to examine facilitators and barriers to implementation (Aim 5). Findings from this study will help to determine how to feasibly implement an effective and sustainable integrated care approach to address SMM disparities.

NCT ID: NCT06335173 Recruiting - Alzheimer Disease Clinical Trials

A Study to Evaluate Efficacy and Safety of Intravenous ACU193 in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

ALTITUDE-AD
Start date: February 29, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the efficacy of ACU193 infusions administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's disease.